Subscribe to RSS - infusion drugs

infusion drugs

OIG tells CMS again: Switch to ASP for infusion drugs


WASHINGTON – The Office of Inspector General in a new report reiterates its concerns that, unlike most Part B drugs, Medicare payment amounts for DME infusion drugs are still based on average wholesale prices from 2003.

OIG: CMS overpays for infusion drugs


WASHINGTON – CMS could have saved $251 million over an 18-month period if it paid for DME infusion drugs using an average sales price methodology, according to a new report from the Office of Inspector General.